AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2023
Jun 13, 2023
35599_dirs_2023-06-13_202773fd-d324-42fc-a287-47bef7f79ffd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2023-06-12
Reporting Person: Brughera Marco Maria (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-06-12 | Stock Option | $8.78 | A | 20000 | Acquired | 2033-06-12 | Common shares (20000) | Direct |
Footnotes
F1: On June 12, 2023, Marco Brughera was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.
F2: The option is 100% vested on date of grant.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20